Clinical Trials on Ovarian Hyperstimulation Syndrome

Total 37426 results

ART Fertility Clinics LLC

Terminated

Progesterone Diurnal Rhythm During Ovarian Stimulation for IVF

Ovarian Hyperstimulation

United Arab Emirates
Ferring Pharmaceuticals

Completed

Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old. (SHOview)

Ovarian Hyperstimulation Syndrome (OHSS)

France
Benha University

Completed

Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention

Ovarian Hyperstimulation

Egypt
Regionshospitalet Viborg, Skive

Completed

Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles

OHSS (Ovarian Hyperstimulation)

Denmark
Bio Genuine (Shanghai) Biotech Co., Ltd.

Not yet recruiting

Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures

Assisted Reproductive Technology | Controlled Ovarian Hyperstimulation

China
Wolfson Medical Center

Withdrawn

Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)

Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)
Etlik Zubeyde Hanim Womens' Health and Teaching...

Completed

Ovarian Hyperstimulation Syndrome and Cabergoline

Ovarian Hyperstimulation Syndrome | Polycystic Ovarian Syndrome
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects

Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early Ovulation

China
Royan Institute

Completed

Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome

Ovarian Hyperstimulation Syndrome

Iran, Islamic Republic of
Royan Institute

Completed

The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

Polycystic Ovary Syndrome | Ovarian Hyperstimulation Syndrome

Iran, Islamic Republic of
Sheba Medical Center

Completed

In Vitro Maturation of Immature Oocytes

Polycystic Ovary Syndrome | Ovarian Hyperstimulation Syndrome

Israel
Bioroma

Unknown

Long Acting GnRH Antagonist in PCOS Women Undergoing IVF

Ovarian Hyperstimulation Syndrome | Polycystic Ovarian Syndrome | Invitro Fertilization

Italy
KK Women's and Children's Hospital

Completed

Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers

Ovarian Hyperstimulation Syndrome

Singapore
Mona M Shaban

Unknown

The Influence of Timing of Cabergoline Initiation on Prevention of OHSS (OHSS)

Ovarian Hyperstimulation Syndrome

Egypt
Elisha Hospital
Merck Sharp & Dohme LLC

Terminated

Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?

Ovarian Hyperstimulation Syndrome

Israel
Eugonia

Unknown

Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)

Ovarian Hyperstimulation Syndrome

Greece
Northwell Health

Withdrawn

In Vitro Maturation (IVM) of Human Oocytes (IVM)

Polycystic Ovarian Syndrome (PCOS) | Patients Sensitive to Exogenous Gonadotropins | Ovarian Hyper Stimulation Syndrome (OHSS)

United States
Eugonia

Unknown

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

Polycystic Ovary Syndrome | Ovarian Hyperstimulation Syndrome

Greece
GeneScience Pharmaceuticals Co., Ltd.
The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaborators

Unknown

Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET

Ovarian Hyperstimulation Syndrome

China
Benha University
Hawaa Fertility Center

Suspended

Montelukast for Prevention & Treatment of OHSS

Ovarian Hyperstimulation Syndrome

Egypt
Ganin Fertility Center

Completed

Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response

Ovarian Hyperstimulation Syndrome

Egypt
ClinAmygate
Cairo University; Al-Azhar University; Beni-Suef University

Completed

Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS

Ovarian Hyperstimulation Syndrome

Egypt
Virginia Center for Reproductive Medicine

Completed

The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors

Ovarian Hyperstimulation Syndrome

United States
Aljazeera Hospital

Completed

Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome

OHSS

Egypt
Al-Azhar University

Not yet recruiting

Ovarian Hyperstimulation Syndrome Using Calcium Infusion

Ovarian Hyperstimulation Syndrome
Sun Yat-sen University

Unknown

Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome

Ovarian Hyperstimulation Syndrome

China
First Affiliated Hospital, Sun Yat-Sen University

Completed

Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS

Ovarian Hyperstimulation Syndrome
Cairo University

Completed

Calcium for Prevention of Ovarian Hyperstimulation Syndrome (OHSS)

Ovarian Hyperstimulation Syndrome

Egypt
University Hospital Schleswig-Holstein

Completed

Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist

Ovarian Hyperstimulation Syndrome

Germany
Yale University

Withdrawn

The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome

Ovarian Hyperstimulation Syndrome

United States
Ferring Pharmaceuticals

Completed

Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide

Ovarian Hyperstimulation Syndrome

Spain
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome

Ovarian Hyperstimulation Syndrome

Spain
San Carlo Public Hospital, Potenza, Italy

Completed

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

Ovarian Hyperstimulation Syndrome

Italy
Royan Institute

Completed

Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program

Ovarian Hyperstimulation Syndrome

Iran, Islamic Republic of
Iakentro Fertility Centre
Aristotle University Of Thessaloniki

Completed

Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS

Ovarian Hyperstimulation Syndrome
University of Connecticut
Organon

Completed

The Use of GnRH Agonist Trigger in the Prevention of OHSS

Ovarian Hyperstimulation Syndrome

United States
UConn Health
Merck Sharp & Dohme LLC

Completed

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

Ovarian Hyperstimulation Syndrome

United States
IVI Madrid

Completed

Endometrial Receptivity After GnRH Agonist Triggering (ERAMAD)

Ovarian Hyperstimulation Syndrome

Spain
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Cabergoline Reduces OHSS

Ovarian Hyperstimulation Syndrome
Benha University

Unknown

Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome

Infertility

Egypt
khalid abd aziz mohamed

Completed

Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome

Infertility

Egypt
Antalya IVF

Withdrawn

The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes

Pregnancy | Ovarian Hyperstimulation Syndrome

Turkey
Benha University

Completed

Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome

Infertility

Egypt
Benha University

Completed

Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (infertility)

Infertility

Egypt
Aljazeera Hospital

Unknown

Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome

OHSS

Egypt
Bagcilar Training and Research Hospital

Unknown

Monitoring the Early Follicular Phase With Androstenedione in Low-dose Step-up Ovulation Induction in High Responders

Infertility | Ovarian Hyperstimulation Syndrome

Turkey
Centre Hospitalier Régional Metz-Thionville

Completed

Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy (PROGEVOL)

Ovarian Hyperstimulation Syndrome | Frozen-thawed Embryo Transfers

France
HaEmek Medical Center, Israel

Withdrawn

Transfer of Fresh Versus Frozen/Thawed Embryos in IVF Cycles Where GnRH Agonist is Utilized for Oocyte Maturation.

Ovarian Hyperstimulation Syndrome | Female | Infertility Drugs
Instituto Valenciano de Infertilidad, IVI VALENCIA
Roche Pharma AG

Completed

Follicular Steroid Genesis in Controlled Ovarian Stimulation (ESTEFOL)

Infertility | Controlled Ovarian Hyperstimulation

Spain
Ain Shams University

Completed

Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome

Assisted Reproduction

Clinical Trials on Ovarian Hyperstimulation Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations